NCT04813601
- Conditions
- Brain Damage, Chronic, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- MarsiCare Arganda, Madrid, Spain
Clinical trial condition
SMA II
Explore clinical trials studying SMA II. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
SMA II trial results
NCT04837157
- Conditions
- Brain Damage, Chronic, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- MarsiCare Arganda, Madrid, Spain
Active, Not Recruiting
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients
NCT05901987
- Conditions
- Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
- Locations
-
- Peking University， First Hospital, Department of Pediatrics Beijing, China
- Bayi Children's Hospital, Seventh Medical Center, PLA general hospital Beijing, China
- West China Second University Hospital, Sichuan University Chengdu, China
- Children's Hospital of Chongqing Medical University Chongqing, China